Dergiler / Uluslararası Hematoloji-Onkoloji Dergisi / 2014 / Cilt: 24 - Sayı: 3

Hodgkin's Disease in a Child with Psoriasis

Sayfa
210–212
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BALCI, Y. I., SENTURK, N., KARADAGLI, E., TASLI, M. L., POLAT, A., KOCYIGIT, A. (2022). Hodgkin's Disease in a Child with Psoriasis. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 24 - Sayı: 3, 210–212. https://ajindex.com/articles/644801

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Asadullah K, Docke WD, Volk HD, Sterry W. The pathophysiological role of cytokines in psoriasis. Drugs Today 35: 913- 924, 1999.
  2. Eichenauer DA, Borchmann P, Engert A. Adolescents with Hodgkin lymphoma: old children or young adults? Leukemia&Lymphoma 53: 1257-1262, 2012. Philip Lanzkowsky. Manual of Pediatric Hematology and Oncology. 5th. edition. United Kingdom, Elsevier, 2011: 599-623.
  3. Raychaudhuri SP, Gross J. A Comparative study of pediatric onset psorias is with adult onset psoriasis. Pediatr Dermatol 17: 174-178, 2000.
  4. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases. Arch Intern Med 165: 2337-2344, 2005.
  5. Jeffes III EW, Lee GC, Said S, et al. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J Invest Dermatol 105: 733-738, 1995.
  6. Margolis D, Bilker W, Hennessy S, et al. The risk of malignancy associated with psoriasis. Arch Dermatol 137: 778-783, 2001.
  7. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis results from a population-based cohort study in the United Kingdom. Arch Dermatol 139: 1425-1429, 2003.
  8. Pai S, Rosenstein ED, Kramer N. Etanercept therapy for psoriatic arthritis in the presence of recurrent non- Hodgkin lymphoma. J Clin Rheumatol 18: 301-303, 2012.